Health
Researchers tie cold viruses used to deliver COVID-19 vaccine to rare blood clot risk – ABS-CBN News
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among…
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among some people who received COVID-19 vaccines made by AstraZeneca Plc and Johnson & Johnson.
The researchers, in a study not yet reviewed by experts, said COVID-19 vaccines that employ adenovirus vectors – cold viruses used to deliver vaccine material – send some of their payload into the nucleus of cells, where some of the instructions…
-
Noosa News22 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News23 hours agoMotorcyclist dies in crash with truck
-
Noosa News24 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
Noosa News21 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
